Reporting standards for angiographic evaluation and endovascular treatment of cerebral arteriovenous malformations

Journal of NeuroInterventional Surgery

Volumn 4, Issue 5, 2012, Pages 325-330

  Jayaraman, Mahesh V ^a   Meyers, Philip M ^b   Derdeyn, Colin P ^c   Fraser, Justin F ^d   Hirsch, Joshua A ^e   Hussain, M Shazam ^f   Blackham, Kristine A ^g   Eskey, Clifford J ^h   Jensen, Mary E ⁱ   Moran, Christopher J ^c   Prestigiacomo, Charles Joseph ^j   Rasmussen, Peter A ^f   McDougall, Cameron G ^k  

^a BROWN UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^h DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

^j RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^k BARROW NEUROLOGICAL INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ENBUCRILATE; ETHYLENE VINYL ACETATE COPOLYMER; ONYX; TRUFILL; UNCLASSIFIED DRUG;

ANESTHESIA; ARTIFICIAL EMBOLISM; BRAIN ANGIOGRAPHY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; CAROTID ARTERIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST; DEATH; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENDOVASCULAR SURGERY; HUMAN; IATROGENIC DISEASE; IMAGE ANALYSIS; INCIDENT REPORT; INCIDENTAL FINDING; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; NEUROMONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROVOCATION TEST; REPORTING STANDARD; REVIEW; RISK ASSESSMENT; STANDARDIZATION;

ANIMALS; CEREBRAL ANGIOGRAPHY; ENDOVASCULAR PROCEDURES; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; PRACTICE GUIDELINES AS TOPIC; RESEARCH REPORT; TREATMENT OUTCOME;

EID: 84866772392     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2011-010173     Document Type: Review

References (62)

1. Mohr JP. A randomized trial of unruptured brain arteriovenous malformations (aruba). Acta Neurochir Suppl 2008;103:3-4.
2. Stapf C, Mohr JP, Choi JH, et al. Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy. Curr Opin Neurol 2006;19:63-8. (Pubitemid 43172707)
3. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476-83. (Pubitemid 16000693)
4. Starke RM, Komotar RJ, Otten ML, et al. Adjuvant embolization with n-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits. Stroke 2009;40:2783-90.
5. Hofmeister C, Stapf C, Hartmann A, et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke 2000;31:1307-10. (Pubitemid 30351250)
6. Stapf C, Mast H, Sciacca RR, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006;66:1350-5. (Pubitemid 43739643)
7. Mast H, Young WL, Koennecke HC, et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet 1997;350:1065-8. (Pubitemid 27437857)
8. da Costa L, Wallace MC, Ter Brugge KG, et al. The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke 2009;40:100-5.
9. Rankin J. Cerebral vascular accidents in patients over the age of 60. III. Diagnosis and treatment. Scott Med J 1957;2:254-68.
10. Connors JJ 3rd, Sacks D, Furlan AJ, et al. Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention. AJNR Am J Neuroradiol 2004;25:1732-41. (Pubitemid 44123699)
11. Meyers PM, Schumacher HC, Higashida RT, et al. Reporting standards for endovascular repair of saccular intracranial cerebral aneurysms. J Vasc Interv Radiol 2009;20:S435-50.
12. Fox AJ, Millar J, Raymond J, et al. Dangerous advances in measurements from digital subtraction angiography: when is a millimeter not a millimeter? AJNR Am J Neuroradiol 2009;30:459-61.
13. Yousem DM, Trinh BC. Injection rates for neuroangiography: results of a survey. AJNR Am J Neuroradiol 2001;22:1838-40. (Pubitemid 33091948)
14. Fifi JT, Meyers PM, Lavine SD, et al. Complications of modern diagnostic cerebral angiography in an academic medical center. J Vasc Interv Radiol 2009;20:442-7.
15. Dawkins AA, Evans AL, Wattam J, et al. Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures. Neuroradiology 2007;49:753-9. (Pubitemid 47382115)
16. Kaufmann TJ, Huston J 3rd, Mandrekar JN, et al. Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology 2007;243:812-19. (Pubitemid 46799436)
17. Cloft HJ, Joseph GJ, Dion JE. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis. Stroke 1999;30:317-20. (Pubitemid 29071796)
18. Fleetwood IG, Marcellus ML, Levy RP, et al. Deep arteriovenous malformations of the basal ganglia and thalamus: natural history. J Neurosurg 2003;98:747-50. (Pubitemid 36401551)
19. Stefani MA, Porter PJ, terBrugge KG, et al. Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke 2002;33:1220-4. (Pubitemid 34517039)
20. Stefani MA, Porter PJ, terBrugge KG, et al. Angioarchitectural factors present in brain arteriovenous malformations associated with hemorrhagic presentation. Stroke 2002;33:920-4. (Pubitemid 34293568)
21. Khaw AV, Mohr JP, Sciacca RR, et al. Association of infratentorial brain arteriovenous malformations with hemorrhage at initial presentation. Stroke 2004;35:660-3. (Pubitemid 38280837)
22. Jayaraman MV, Marcellus ML, Do HM, et al. Hemorrhage rate in patients with Spetzler-Martin grades IV and V arteriovenous malformations: is treatment justified? Stroke 2007;38:325-9. (Pubitemid 46184303)
23. Han PP, Ponce FA, Spetzler RF. Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg 2003;98:3-7. (Pubitemid 36050440)
24. Duong DH, Young WL, Vang MC, et al. Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations. Stroke 1998;29:1167-76. (Pubitemid 28265473)
25. Marks MP, Lane B, Steinberg GK, et al. Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants. Radiology 1990;176:807-13. (Pubitemid 20266776)
26. Perata HJ, Tomsick TA, Tew JM Jr. Feeding artery pedicle aneurysms: association with parenchymal hemorrhage and arteriovenous malformation in the brain. J Neurosurg 1994;80:631-4. (Pubitemid 24100282)
27. Redekop G, TerBrugge K, Montanera W, et al. Arterial aneurysms associated with cerebral arteriovenous malformations: classification, incidence, and risk of hemorrhage. J Neurosurg 1998;89:539-46. (Pubitemid 28440921)
28. Stapf C, Mohr JP, Sciacca RR, et al. Incident hemorrhage risk of brain arteriovenous malformations located in the arterial borderzones. Stroke 2000;31:2365-8.
29. Du R, Keyoung HM, Dowd CF, et al. The effects of diffuseness and deep perforating artery supply on outcomes after microsurgical resection of brain arteriovenous malformations. Neurosurgery 2007;60:638-46.
30. Lasjaunias PL, Landrieu P, Rodesch G, et al. Cerebral proliferative angiopathy: clinical and angiographic description of an entity different from cerebral AVMs. Stroke 2008;39:878-85. (Pubitemid 351619547)
31. Jafar JJ, Davis AJ, Berenstein A, et al. The effect of embolization with n-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg 1993;78:60-9. (Pubitemid 23005354)
32. DeMeritt JS, Pile-Spellman J, Mast H, et al. Outcome analysis of preoperative embolization with n-butyl cyanoacrylate in cerebral arteriovenous malformations. AJNR Am J Neuroradiol 1995;16:1801-7.
33. Vinuela F, Dion JE, Duckwiler G, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg 1991;75:856-64.
34. Gobin YP, Laurent A, Merienne L, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg 1996;85:19-28. (Pubitemid 26195033)
35. Miyachi S, Negoro M, Okamoto T, et al. Embolisation of cerebral arteriovenous malformations to assure successful subsequent radiosurgery. J Clin Neurosci 2000;7(Suppl 1):82-5.
36. Panagiotopoulos V, Gizewski E, Asgari S, et al. Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 2009;30:99-106.
37. Katsaridis V, Papagiannaki C, Aimar E. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 2008;50:589-97.
38. Jayaraman M, Cloft HJ. Embolization of brain arteriovenous malformations for cure: because we could or because we should? AJNR Am J Neuroradiol 2009;30:107-8.
39. Katsaridis V, Papagiannaki C, Aimar E. Embolization of brain arteriovenous malformations for cure: because we could and because we should. AJNR Am J Neuroradiol 2009;30:e67.
40. Heidenreich JO, Hartlieb S, Stendel R, et al. Bleeding complications after endovascular therapy of cerebral arteriovenous malformations. AJNR Am J Neuroradiol 2006;27:313-16. (Pubitemid 44897831)
41. Weber W, Kis B, Siekmann R, et al. Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects. AJNR Am J Neuroradiol 2007;28:371-7. (Pubitemid 46281065)
42. Weber W, Kis B, Siekmann R, et al. Preoperative embolization of intracranial arteriovenous malformations with onyx. Neurosurgery 2007;61:244-52. (Pubitemid 47357292)
43. van Rooij WJ, Sluzewski M, Beute GN. Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 2007;28:172-7. (Pubitemid 46147561)
44. Mounayer C, Hammami N, Piotin M, et al. Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 2007;28:518-23. (Pubitemid 46481897)
45. Florio F, Lauriola W, Nardella M, et al. Endovascular treatment of intracranial arteriovenous malformations with onyx embolization: preliminary experience. Radiol Med 2003;106:512-20. (Pubitemid 38155412)
46. Jahan R, Murayama Y, Gobin YP, et al. Embolization of arteriovenous malformations with onyx: clinicopathological experience in 23 patients. Neurosurgery 2001;48:984-95.
47. Velat GJ, Reavey-Cantwell JF, Sistrom C, et al. Comparison of n-butyl cyanoacrylate and Onyx for the embolization of intracranial arteriovenous malformations: analysis of fluoroscopy and procedure times. Neurosurgery 2008;63:ONS73-8.
48. Feliciano CE, de Leon-Berra R, Hernandez-Gaitan MS, et al. Provocative test with propofol: experience in patients with cerebral arteriovenous malformations who underwent neuroendovascular procedures. AJNR Am J Neuroradiol 2010;31:470-5.
49. Moo LR, Murphy KJ, Gailloud P, et al. Tailored cognitive testing with provocative amobarbital injection preceding avm embolization. AJNR Am J Neuroradiol 2002;23:416-21. (Pubitemid 34241323)
50. Barr JD, Mathis JM, Horton JA. Provocative pharmacologic testing during arterial embolization. Neurosurg Clin N Am 1994;5:403-11.
51. Debrun GM, Aletich V, Ausman JI, et al. Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 1997;40:112-20.
52. Lee GP, Meador KJ, Murro AM, et al. Amobarbital evaluation of neurobehavioral function prior to therapeutic occlusion of brain arteriovenous malformations: a new neuropsychological procedure. Appl Neuropsychol 1996;3:1-7. (Pubitemid 126730274)
53. Rauch RA, Vinuela F, Dion J, et al. Preembolization functional evaluation in brain arteriovenous malformations: the ability of superselective amytal test to predict neurologic dysfunction before embolization. AJNR Am J Neuroradiol 1992;13:309-14.
54. Purdy PD, Batjer HH, Samson D, et al. Intraarterial sodium amytal administration to guide preoperative embolization of cerebral arteriovenous malformations. J Neurosurg Anesthesiol 1991;3:103-6.
55. Iancu-Gontard D, Weill A, Guilbert F, et al. Inter- and intraobserver variability in the assessment of brain arteriovenous malformation angioarchitecture and endovascular treatment results. AJNR Am J Neuroradiol 2007;28:524-7. (Pubitemid 46481898)
56. Reig A, Rajaram R, Simon S, et al. Complete angiographic obliteration of intracranial AVMs with endovascular embolization: incomplete embolic nidal opacification is associated with AVM recurrance. J Neurointerventional Surg 2010;2:202-7.
57. Hartmann A, Mast H, Mohr JP, et al. Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke 2005;36:2431-5. (Pubitemid 41566972)
58. Choi JH, Mast H, Sciacca RR, et al. Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke 2006;37:1243-7. (Pubitemid 43731870)
59. Kim LJ, Albuquerque FC, Spetzler RF, et al. Postembolization neurological deficits in cerebral arteriovenous malformations: stratification by arteriovenous malformation grade. Neurosurgery 2006;59:53-9.
60. Haw CS, ter Brugge K, Willinsky R, et al. Complications of embolization of arteriovenous malformations of the brain. J Neurosurg 2006;104:226-32.
61. Jayaraman MV, Marcellus ML, Hamilton S, et al. Neurologic complications of arteriovenous malformation embolization using liquid embolic agents. AJNR Am J Neuroradiol 2008;29:242-6. (Pubitemid 351287874)
62. Gao K, Yang XJ, Mu SQ, et al. Embolization of brain arteriovenous malformations with ethylene vinyl alcohol copolymer: technical aspects. Chin Med J (Engl) 2009;122:1851-6.